APA (7th ed.) Citation

E, G., DY, O., A, I., PL, B., JP, D., E, C., . . . B, W. (2024). Pharmacokinetics (PK) of Tiragolumab in First-in-Human Study in Patients with Mixed Solid Tumors (GO30103). Journal of clinical pharmacology, 64(5), 544. https://doi.org/10.1002/jcph.2397

Chicago Style (17th ed.) Citation

E, Garralda, et al. "Pharmacokinetics (PK) of Tiragolumab in First-in-Human Study in Patients with Mixed Solid Tumors (GO30103)." Journal of Clinical Pharmacology 64, no. 5 (2024): 544. https://doi.org/10.1002/jcph.2397.

MLA (9th ed.) Citation

E, Garralda, et al. "Pharmacokinetics (PK) of Tiragolumab in First-in-Human Study in Patients with Mixed Solid Tumors (GO30103)." Journal of Clinical Pharmacology, vol. 64, no. 5, 2024, p. 544, https://doi.org/10.1002/jcph.2397.